Logo image of PBHC

PATHFINDER BANCORP INC (PBHC) Stock Fundamental Analysis

NASDAQ:PBHC - US70319R1095 - Common Stock

14.92 USD
+0.12 (+0.81%)
Last: 8/27/2025, 8:11:08 PM
Fundamental Rating

2

Taking everything into account, PBHC scores 2 out of 10 in our fundamental rating. PBHC was compared to 393 industry peers in the Banks industry. PBHC may be in some trouble as it scores bad on both profitability and health. PBHC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year PBHC was profitable.
In the past year PBHC had a positive cash flow from operations.
PBHC had positive earnings in each of the past 5 years.
PBHC had a positive operating cash flow in each of the past 5 years.
PBHC Yearly Net Income VS EBIT VS OCF VS FCFPBHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

1.2 Ratios

PBHC's Return On Assets of 0.22% is on the low side compared to the rest of the industry. PBHC is outperformed by 86.51% of its industry peers.
The Return On Equity of PBHC (2.57%) is worse than 84.99% of its industry peers.
Industry RankSector Rank
ROA 0.22%
ROE 2.57%
ROIC N/A
ROA(3y)0.46%
ROA(5y)0.51%
ROE(3y)5.73%
ROE(5y)6.23%
ROIC(3y)N/A
ROIC(5y)N/A
PBHC Yearly ROA, ROE, ROICPBHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

PBHC has a Profit Margin of 6.18%. This is amonst the worse of the industry: PBHC underperforms 86.77% of its industry peers.
PBHC's Profit Margin has declined in the last couple of years.
PBHC does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 6.18%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-37.58%
PM growth 5Y-14.02%
GM growth 3YN/A
GM growth 5YN/A
PBHC Yearly Profit, Operating, Gross MarginsPBHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

More info and screens

1

2. Health

2.1 Basic Checks

PBHC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PBHC has more shares outstanding
PBHC has more shares outstanding than it did 5 years ago.
The debt/assets ratio for PBHC is higher compared to a year ago.
PBHC Yearly Shares OutstandingPBHC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
PBHC Yearly Total Debt VS Total AssetsPBHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

The Debt to FCF ratio of PBHC is 3.36, which is a good value as it means it would take PBHC, 3.36 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.36, PBHC is doing worse than 61.83% of the companies in the same industry.
A Debt/Equity ratio of 0.37 indicates that PBHC is not too dependend on debt financing.
The Debt to Equity ratio of PBHC (0.37) is worse than 73.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 3.36
Altman-Z N/A
ROIC/WACCN/A
WACC18.14%
PBHC Yearly LT Debt VS Equity VS FCFPBHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
PBHC Yearly Current Assets VS Current LiabilitesPBHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

More info and screens

2

3. Growth

3.1 Past

PBHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -52.34%.
The earnings per share for PBHC have been decreasing by -12.05% on average. This is quite bad
PBHC shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.08%.
PBHC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.80% yearly.
EPS 1Y (TTM)-52.34%
EPS 3Y-38.16%
EPS 5Y-12.05%
EPS Q2Q%39.49%
Revenue 1Y (TTM)19.08%
Revenue growth 3Y4.32%
Revenue growth 5Y8.8%
Sales Q2Q%12.97%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PBHC Yearly Revenue VS EstimatesPBHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 28.69, which means the current valuation is very expensive for PBHC.
Compared to the rest of the industry, the Price/Earnings ratio of PBHC indicates a rather expensive valuation: PBHC more expensive than 85.24% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.14. PBHC is around the same levels.
Industry RankSector Rank
PE 28.69
Fwd PE N/A
PBHC Price Earnings VS Forward Price EarningsPBHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

PBHC's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PBHC is cheaper than 92.37% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.13
EV/EBITDA N/A
PBHC Per share dataPBHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.74%, PBHC has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.30, PBHC has a dividend in line with its industry peers.
PBHC's Dividend Yield is comparable with the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 2.74%

5.2 History

On average, the dividend of PBHC grows each year by 7.64%, which is quite nice.
PBHC has been paying a dividend for at least 10 years, so it has a reliable track record.
PBHC has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)7.64%
Div Incr Years4
Div Non Decr Years14
PBHC Yearly Dividends per sharePBHC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

PBHC pays out 77.49% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of PBHC has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP77.49%
EPS Next 2YN/A
EPS Next 3YN/A
PBHC Yearly Income VS Free CF VS DividendPBHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
PBHC Dividend Payout.PBHC Dividend Payout, showing the Payout Ratio.PBHC Dividend Payout.PayoutRetained Earnings

More info and screens

PATHFINDER BANCORP INC

NASDAQ:PBHC (8/27/2025, 8:11:08 PM)

14.92

+0.12 (+0.81%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)08-04 2025-08-04
Earnings (Next)10-28 2025-10-28
Inst Owners19.38%
Inst Owner Change13.26%
Ins Owners13.19%
Ins Owner Change0.19%
Market Cap71.47M
Analysts0
Price TargetN/A
Short Float %0.15%
Short Ratio1.33
Dividend
Industry RankSector Rank
Dividend Yield 2.74%
Yearly Dividend0.4
Dividend Growth(5Y)7.64%
DP77.49%
Div Incr Years4
Div Non Decr Years14
Ex-Date07-18 2025-07-18 (0.1)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 28.69
Fwd PE N/A
P/S 1.37
P/FCF 5.13
P/OCF 4.36
P/B 0.57
P/tB 0.63
EV/EBITDA N/A
EPS(TTM)0.52
EY3.49%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.91
FCFY19.5%
OCF(TTM)3.42
OCFY22.95%
SpS10.86
BVpS26.07
TBVpS23.8
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.22%
ROE 2.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 6.18%
GM N/A
FCFM 26.78%
ROA(3y)0.46%
ROA(5y)0.51%
ROE(3y)5.73%
ROE(5y)6.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-37.58%
PM growth 5Y-14.02%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 3.36
Debt/EBITDA N/A
Cap/Depr 136.11%
Cap/Sales 4.75%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 433.24%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC18.14%
ROIC/WACCN/A
Cap/Depr(3y)248.61%
Cap/Depr(5y)177.19%
Cap/Sales(3y)6.52%
Cap/Sales(5y)5.11%
Profit Quality(3y)236.67%
Profit Quality(5y)350.25%
High Growth Momentum
Growth
EPS 1Y (TTM)-52.34%
EPS 3Y-38.16%
EPS 5Y-12.05%
EPS Q2Q%39.49%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)19.08%
Revenue growth 3Y4.32%
Revenue growth 5Y8.8%
Sales Q2Q%12.97%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-26.4%
FCF growth 3Y-21.54%
FCF growth 5Y15.14%
OCF growth 1Y-30.71%
OCF growth 3Y-17.76%
OCF growth 5Y6.66%